Progranulin, a glycoprotein deficient in frontotemporal dementia, is a novel substrate of several protein disulfide isomerase family proteins

PLoS ONE

Volumn 6, Issue 10, 2011, Pages

  Almeida, Sandra ^a   Zhou, Lijuan ^b,c   Gao, Fen Biao ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b GLADSTONE INSTITUTE OF NEUROLOGICAL DISEASE   (United States)

^c GENENTECH INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CALCIUM BINDING PROTEIN; CALRETICULIN; CHAPERONE; ENDOPLASMIC RETICULUM P5 PROTEIN; ENDOPLASMIC RETICULUM P57 PROTEIN; ENDOPLASMIC RETICULUM P72 PROTEIN; GLUCOSE REGULATED PROTEIN 78; GLUCOSE REGULATED PROTEIN 94; HEAT SHOCK PROTEIN 70; HEAT SHOCK PROTEIN 70 1; PROGRANULIN; PROTEIN DISULFIDE ISOMERASE; UNCLASSIFIED DRUG; BIOLOGICAL MARKER; GLYCOPROTEIN; GRN PROTEIN, MOUSE; PDIA3 PROTEIN, HUMAN; PDIA6 PROTEIN, HUMAN; SIGNAL PEPTIDE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BRAIN CELL; CONTROLLED STUDY; ENDOPLASMIC RETICULUM; FRONTOTEMPORAL DEMENTIA; GOLGI COMPLEX; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; MASS SPECTROMETRY; MICROGLIA; MOLECULAR SIZE; MOUSE; NERVE CELL CULTURE; NONHUMAN; PROTEIN ANALYSIS; PROTEIN CROSS LINKING; PROTEIN DEFECT; PROTEIN EXPRESSION; PROTEIN FAMILY; PROTEIN LOCALIZATION; PROTEIN SECRETION; ANIMAL; BRAIN CORTEX; CELL STRAIN HEK293; CYTOLOGY; GENE EXPRESSION REGULATION; METABOLISM; NERVE CELL; PROTEIN BINDING; PROTEIN TRANSPORT; SECRETION;

ANIMALS; BIOLOGICAL MARKERS; CEREBRAL CORTEX; ENDOPLASMIC RETICULUM; FRONTOTEMPORAL DEMENTIA; GENE EXPRESSION REGULATION; GLYCOPROTEINS; HEK293 CELLS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICE; MICROGLIA; MOLECULAR CHAPERONES; NEURONS; PROTEIN BINDING; PROTEIN DISULFIDE-ISOMERASES; PROTEIN TRANSPORT;

EID: 80054737024     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0026454     Document Type: Article

References (30)

1. Vossel KA, Miller BL, (2008) New approaches to the treatment of frontotemporal lobar degeneration. Curr Opin Neurol 21: 708-716.
2. Boxer AL, Miller BL, (2005) Clinical features of frontotemporal dementia. Alzheimer Dis Assoc Disord. 19 (Suppl 1): S36.
3. Baker M, Mackenzie IR, Pickering-Brown SM, Gass J, Rademakers R, et al. (2006) Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 442: 916-919.
4. Cruts M, Gijselinck I, van der Zee J, Engelborghs S, Wils H, et al. (2006) Null mutations in progranulin cause ubiquitin-positive frontotemporal dementia linked to chromosome 17q21. Nature 442: 920-924.
5. Gijselinck I, van der Zee J, Engelborghs S, Goossens D, Peeters K, et al. (2008) Progranulin locus deletion in frontotemporal dementia. Hum Mutat 29: 53-58.
6. van der Zee J, Le Ber I, Maurer-Stroh S, Engelborghs S, Gijselinck I, et al. (2007) Mutations other than null mutations producing a pathogenic loss of progranulin in frontotemporal dementia. Hum Mutat 28: 416.
7. Rovelet-Lecrux A, Deramecourt V, Legallic S, Maurage CA, Le Ber I, et al. (2008) Deletion of the progranulin gene in patients with frontotemporal lobar degeneration or Parkinson disease. Neurobiol Dis 31: 41-45.
8. Wang J, Van Damme P, Cruchaga C, Gitcho MA, Vidal JM, et al. (2010) Pathogenic cysteine mutations affect progranulin function and production of mature granulins. J Neurochem 112: 1305-1315.
9. Cenik B, Sephton CF, Dewey CM, Xian X, Wei S, et al. (2011) Suberoylanilide hydroxamic acid (vorinostat) up-regulates progranulin transcription: rational therapeutic approach to frontotemporal dementia. J Biol Chem 286: 16101-16108.
10. Jiao J, Herl LD, Farese RV, Gao F-B, (2010) MicroRNA-29b regulates the expression level of human progranulin, a secreted glycoprotein implicated in frontotemporal dementia. PLoS One 5: e10551.
11. Wang WX, Wilfred BR, Madathil SK, Tang G, Hu Y, et al. (2010) miR-107 regulates granulin/progranulin with implications for traumatic brain injury and neurodegenerative disease. Am J Pathol 177: 334-345.
12. Rademakers R, Eriksen JL, Baker M, Robinson T, Ahmed Z, et al. (2008) Common variation in the miR-659 binding-site of GRN is a major risk factor for TDP43-positive frontotemporal dementia. Hum Mol Genet 17: 3631-3642.
13. Capell A, Liebscher S, Fellerer K, Brouwers N, Willem M, et al. (2011) Rescue of progranulin deficiency associated with frontotemporal lobar degeneration by alkalizing reagents and inhibition of vacuolar ATPase. J Neurosci 31: 1885-1894.
14. Hu F, Padukkavidana T, Vægter CB, Brady OA, Zheng Y, et al. (2010) Sortilin-mediated endocytosis determines levels of the frontotemporal dementia protein, progranulin. Neuron 68: 654-667.
15. Carrasquillo MM, Nicholson AM, Finch N, Gibbs JR, Baker M, et al. (2010) Genome-wide screen identifies rs646776 near sortilin as a regulator of progranulin levels in human plasma. Am J Hum Genet 87: 890-897.
16. He Z, Bateman A, (2003) Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J Mol Med 81: 600-612.
17. Petkau TL, Neal SJ, Orban PC, MacDonald JL, Hill AM, et al. (2010) Progranulin expression in the developing and adult murine brain. J Comp Neurol 518: 3931-3947.
18. Daniel R, Daniels E, He Z, Bateman A, (2003) Progranulin (acrogranin/PC cell-derived growth factor/granulin-epithelin precursor) is expressed in the placenta, epidermis, microvasculature, and brain during murine development. Dev Dyn 227: 593-599.
19. Kayasuga Y, Chiba S, Suzuki M, Kikusui T, Matsuwaki T, et al. (2007) Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Behav Brain Res 185: 110-118.
20. Ni M, Amy S, Lee AS, (2007) ER chaperones in mammalian development and human diseases. FEBS Lett 581: 3641-3651.
21. Frand AR, Cuozzo JW, Kaiser CA, (2000) Pathways for protein disulphide bond formation. Trends Cell Biol 10: 203-210.
22. Ellgaard L, Ruddock LW, (2005) The human protein disulphide isomerase family: substrate interactions and functional properties. EMBO Rep 6: 28-32.
23. Coe H, Michalak M, (2010) ERp57, a multifunctional endoplasmic reticulum resident oxidoreductase. Int J Biochem Cell Biol 42: 796-799.
24. Songsrirote K, Li Z, Ashford D, Bateman A, Thomas-Oates J, (2010) Development and application of mass spectrometric methods for the analysis of progranulin N-glycosylation. J Proteomics 73: 1479-1490.
25. Oliver JD, van der Wal FJ, Bulleid NJ, High S, (1997) Interaction of the thiol-dependent reductase ERp57 with nascent glycoproteins. Science 275: 86-88.
26. Morrice NA, Powis SJ, (1998) A role for the thiol-dependent reductase ERp57 in the assembly of MHC class I molecules. Curr Biol 8: 713-716.
27. Rutkevich LA, Cohen-Doyle MF, Brockmeier U, Williams DB, (2010) Functional relationship between protein disulfide isomerase family members during the oxidative folding of human secretory proteins. Mol Biol Cell 21: 3093-3105.
28. Kozlov G, Maattanen P, Schrag JD, Hura GL, Gabrielli L, et al. (2009) Structure of the noncatalytic domains and global fold of the protein disulfide isomerase ERp72. Structure 17: 651-659.
29. Kozlov G, Azeroual S, Rosenauer A, Määttänen P, Denisov AY, et al. (2010) Structure of the catalytic a(0)a fragment of the protein disulfide isomerase ERp72. J Mol Biol 401: 618-625.
30. Kayasuga Y, Chiba S, Suzuki M, Kikusui T, Matsuwaki T, Yamanouchi K, Kotaki H, Horai R, Iwakura Y, Nishihara M, (2007) Alteration of behavioural phenotype in mice by targeted disruption of the progranulin gene. Behav Brain Res 185: 110-118.